We can’t show the full text here under this license. Use the link below to read it at the source.
Exosomal miR-29a-3p derived from bone marrow stromal cells suppresses malignant behavior of NSCLC by regulating DNMT3A/JAK2/STAT3 axis
Bone marrow cell particles containing miR-29a-3p may reduce lung cancer growth by affecting the DNMT3A/JAK2/STAT3 pathway
AI simplified
Abstract
In non-small cell lung cancer (NSCLC), decreased levels of or increased levels of are associated with poor prognosis.
- miR-29a-3p can be transported from bone marrow mesenchymal stem cells to A549 cells via .
- Increased levels of miR-29a-3p inhibit cell proliferation and migration while promoting apoptosis in NSCLC cells.
- DNMT3A was identified as a target gene of miR-29a-3p and is involved in the regulation of the JAK2/STAT3 signaling pathway.
- Upregulation of miR-29a-3p leads to decreased expression of DNMT3A and impairment of the JAK2/STAT3 signaling pathway.
AI simplified
Key numbers
1029
NSCLC Samples Analyzed
Total number of NSCLC samples from UCSC database.
110
Normal Samples Analyzed
Total number of normal samples used for comparison in the study.
123 nm
Average Diameter of
Size of isolated from bone marrow stromal cells.